[Federal Register: April 24, 2009 (Volume 74, Number 78)]
[Notices]
[Page 18697-18698]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr24ap09-40]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Defense Health Board (DHB) Meeting
AGENCY: Department of Defense.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: Pursuant to the Federal Advisory Committee Act of 1972 (5
U.S.C., Appendix as amended), the Sunshine in the Government Act of
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.150, and in
accordance with section 10(a)(2) of Public Law, the following meeting
of the Defense Health Board (DHB) is announced:
DATES: May 7-8, 2009.
May 7, 2009.
7 a.m.-12 p.m. (Open Session).
12 p.m.-2:15 p.m. (Administrative Working Meeting).
2:15 p.m.-5:15 p.m. (Open Session).
May 8, 2009.
8 a.m.-2 p.m. (Closed Session).
ADDRESSES: May 7, 2009, Ballroom, Sheraton Chrystal City Hotel, 1800
Jefferson Davis Highway Arlington, VA 22202.
May 8, 2009 Industrial College of the Armed Forces, Fort McNair,
Washington, DC.
FOR FURTHER INFORMATION CONTACT: Commander Edmond F. Feeks, Executive
Secretary, Defense Health Board, Five Skyline Place, 5111 Leesburg
Pike, Suite 810, Falls Church, Virginia 22041-3206, (703) 681-8448,
EXT. 1228, Fax: (703)-681-3317, edmond.feeks@tma.osd.mil. Additional
information, agenda updates, and meeting registration are available
online at the Defense Health Board Web site, http://www.ha.osd.mil/dhb.
The public is encouraged to register for the meeting. If special
accommodations are required to attend (sign language, wheelchair
accessibility) please contact Ms. Lisa Jarrett at (703) 681-8448 ext.
1280 by April 30, 2009. Written statements may be mailed to the above
address, emailed to dhb@ha.osd.mil or faxed to (703) 681-3317.
SUPPLEMENTARY INFORMATION:
Purpose of the Meeting: The purpose of the meeting is to address
and deliberate pending and new Board issues and provide briefings for
Board members on topics related to ongoing Board business.
Agenda: On May 7, 2009, the Board will receive a briefing on Iraqi
Health
[[Page 18698]]
Sector Reconstruction. The following Defense Health Board Subcommittees
will present updates to the Board: the Millennium Cohort Study, the
Psychological Health External Advisory Subcommittee, the Trauma and
Injury Subcommittee, the Vaccine Safety and Effectiveness Report, the
National Capital Region Base Realignment and Closure Subcommittee, and
the Traumatic Brain Injury External Advisory Subcommittee. The Board
will also receive an informational briefing on the use of the Warren
Cohort Serum Repository.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR102-3.155, in the
interest of national security, the Department of Defense has determined
that the meeting on May 8, 2009 will be closed to the public. The Under
Secretary of Defense (Personnel and Readiness), in consultation with
the Office of the DoD General Counsel, has determined in writing that
the public interest requires that the session on May 8, 2009 be closed
to public because they will concern matters listed in section
552b(c)(1) of title 5, United States Code. Specifically the information
presented meets criteria established by an executive order to be kept
secret in the interest of national defense and foreign policy.
Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102-3.140 through
102-3.165 and subject availability of space, the Defense Health Board
meeting from 7 a.m. to 12 p.m. and from 2:15 p.m. to 5:15 p.m. on May
7, 2009 is open to the public. Any member of the public wishing to
provide input to the Defense Health Board should submit a written
statement in accordance with 41 CFR 102-3.140(C) and section 10(a)(3)
of the Federal Advisory Committee Act, and the procedures described in
this notice. Written statement should be not longer than two type-
written pages and must address the following detail: The issue,
discussion, and a recommended course of action. Supporting
documentation may also be included as needed to establish the
appropriate historical context and to provide any necessary background
information.
Individuals desiring to submit a written statement may do so
through the Board's Designated Federal Officer at the address detailed
above at any point. However, if the written statement is not received
at least 10 calendar days prior to the meeting, which is subject to
this notice, then it may not be provided to or considered by the
Defense Health Board until the next open meeting.
The Designated Federal Officer will review all timely submissions
with the Defense Health Board Chairperson, and ensure they are provided
to members of the Defense Health Board before the meeting that is
subject to this notice. After reviewing the written comments, the
Chairperson and the Designated Federal Officer may choose to invite the
submitter of the comments to orally present their issue during an open
portion of this meeting or at a future meeting.
The Designated Federal Officer, in consultation with the Defense
Health Board Chairperson, may, if desired, allot a specific amount of
time for members of the public to present their issues for review and
discussion by the Defense Health Board.
Dated: April 20, 2009.
Morgan E. Frazier,
Alternate OSD Federal Register, Liaison Officer, Department of Defense.
[FR Doc. E9-9390 Filed 4-23-09; 8:45 am]
BILLING CODE 5001-06-P